Literature DB >> 24203439

Innate immune responses to HIV infection in the central nervous system.

Rebeca Geffin1, Micheline McCarthy.   

Abstract

Human immunodeficiency virus (HIV) invades the brain early during infection and generates a chronic inflammatory microenvironment that can eventually result in neurological disease, even in the absence of significant viral replication. Thus, HIV-1 infection of the brain has been characterized both as a neuroimmunological and neurodegenerative disorder. While the brain and central nervous system (CNS) have historically been regarded as immune privileged or immunologically quiescent, newer concepts of CNS immunity suggest an important if not defining role for innate immune responses generated by glial cells. Innate immunity may be the first line of defense against HIV infection of the brain and CNS, with multiple cellular elements providing responses that can be anti-viral and neuroprotective, but also potentially neurotoxic, impairing neurogenesis and promoting neuronal apoptosis. To investigate the effects of HIV exposure on neurogenesis and neuronal survival, we have studied the responses of human neuroepithelial progenitor (NEP) cells, which undergo directed differentiation into astrocytes and neurons in vitro. We identified a group of genes that were differentially expressed in NEP-derived cells during virus exposure. This included genes that are strongly related to interferon-induced responses and antigen presentation. Moreover, we observed that the host factor apolipoprotein E influences the innate immune response expressed by these cells, with a more robust response in the apolipoprotein E3/E3 genotype cultures compared to the apolipoprotein E3/E4 counterparts. Thus, neuroepithelial progenitors and their differentiated progeny recognize HIV and respond to it by mounting an innate immune response with a vigor that is influenced by the host factor apolipoprotein E.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24203439     DOI: 10.1007/s12026-013-8445-4

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  113 in total

1.  Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta.

Authors:  I Y Chung; E N Benveniste
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

2.  APOE genotype in cerebrovascular disease and vascular dementia.

Authors:  A Frank; E Díez-Tejedor; M J Bullido; F Valdivieso; P Barreiro
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

3.  Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain.

Authors:  V H Perry; D A Hume; S Gordon
Journal:  Neuroscience       Date:  1985-06       Impact factor: 3.590

Review 4.  Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism.

Authors:  K Muthumani; A Y Choo; A Premkumar; D S Hwang; K P Thieu; B M Desai; D B Weiner
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

5.  Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry.

Authors:  O Bagasra; E Lavi; L Bobroski; K Khalili; J P Pestaner; R Tawadros; R J Pomerantz
Journal:  AIDS       Date:  1996-06       Impact factor: 4.177

6.  Early dysregulation of cripto-1 and immunomodulatory genes in the cerebral cortex in a macaque model of neuroAIDS.

Authors:  Edward B Stephens; Mollie Jackson; Lisa Cui; Eric Pacyniak; Rajani Choudhuri; Christopher S Liverman; David S Salomon; Nancy E J Berman
Journal:  Neurosci Lett       Date:  2006-11-03       Impact factor: 3.046

7.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

8.  Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.

Authors:  Eleanor S Roberts; Michelle A Zandonatti; Debbie D Watry; Lisa J Madden; Steven J Henriksen; Michael A Taffe; Howard S Fox
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

9.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection.

Authors:  L E Davis; B L Hjelle; V E Miller; D L Palmer; A L Llewellyn; T L Merlin; S A Young; R G Mills; W Wachsman; C A Wiley
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

10.  Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders.

Authors:  Alejandra Borjabad; Susan Morgello; Wei Chao; Seon-Young Kim; Andrew I Brooks; Jacinta Murray; Mary Jane Potash; David J Volsky
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

View more
  3 in total

Review 1.  Multiple Sclerosis and Subsequent Human Immunodeficiency Virus Infection: A Case with the Rare Comorbidity, Focus on Novel Treatment Issues and Review of the Literature.

Authors:  Charalampos Skarlis; Maria Gontika; Serafeim Katsavos; Giorgios Velonakis; Panagiotis Toulas; Maria Anagnostouli
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

2.  Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains.

Authors:  Weizhe Li; Santhi Gorantla; Howard E Gendelman; Larisa Y Poluektova
Journal:  Dis Model Mech       Date:  2017-12-19       Impact factor: 5.758

3.  Auditory Alterations in Children Infected by Human Immunodeficiency Virus Verified Through Auditory Processing Test.

Authors:  Ana Carla Leite Romero; Lívia Marangoni Alfaya; Alina Sanches Gonçales; Ana Claudia Figueiredo Frizzo; Myriam de Lima Isaac
Journal:  Int Arch Otorhinolaryngol       Date:  2016-03-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.